Apolipoproteína C3 (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apolipoproteína C3" in Galician language version.

refsWebsite

Global rank Galician rank

12nih.gov

4^th place

6^th place

12doi.org

2^nd place

7^th place

doi.org

dx.doi.org

Khetarpal SA, Zeng X, Millar JS, Vitali C, Somasundara AVH, Zanoni P, Landro JA, Barucci N, Zavadoski WJ, Sun Z, de Haard H, Toth IV, Peloso GM, Natarajan P, Cuchel M, Lund-Katz S, Phillips MC, Tall AR, Kathiresan S, DaSilva-Jardine P, Yates NA, Rader D (2017). "A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels". Nature Medicine 23 (9): 1086–1094. PMC 5669375. PMID 28825717. doi:10.1038/nm.4390.
Vaith P, Assmann G, Uhlenbruck G (xuño de 1978). "Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins". Biochimica et Biophysica Acta (BBA) - General Subjects 541 (2): 234–40. PMID 208636. doi:10.1016/0304-4165(78)90396-3.
Nicolardi S, van der Burgt YE, Dragan I, Hensbergen PJ, Deelder AM (maio de 2013). "Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera". Journal of Proteome Research 12 (5): 2260–68. PMID 23527852. doi:10.1021/pr400136p.
Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM (febreiro de 2010). "Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins". Arteriosclerosis, Thrombosis, and Vascular Biology 30 (2): 239–45. PMC 2818784. PMID 19910636. doi:10.1161/ATVBAHA.109.197830.
Sundaram M, Zhong S, Bou Khalil M, Links PH, Zhao Y, Iqbal J, Hussain MM, Parks RJ, Wang Y, Yao Z (xaneiro de 2010). "Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions". Journal of Lipid Research 51 (1): 150–161. PMC 2789775. PMID 19622837. doi:10.1194/M900346-JLR200.
Sundaram M, Zhong S, Bou Khalil M, Zhou H, Jiang ZG, Zhao Y, Iqbal J, Hussain MM, Figeys D, Wang Y, Yao Z (xuño de 2010). "Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia". Journal of Lipid Research 51 (6): 1524–1534. PMC 3035516. PMID 20097930. doi:10.1194/jlr.M005108.
Qin W, Sundaram M, Wang Y, Zhou H, Zhong S, Chang CC, Manhas S, Yao EF, Parks RJ, McFie PJ, Stone SJ, Jiang ZG, Wang C, Figeys D, Jia W, Yao Z (agosto de 2011). "Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen". The Journal of Biological Chemistry 286 (31): 27769–27780. PMC 3149367. PMID 21676879. doi:10.1074/jbc.M110.203679.
Singh P, Singh M, Kaur TP, Grewal SS (novembro de 2008). "A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease". International Journal of Cardiology 130 (3): e93–5. PMID 17825930. doi:10.1016/j.ijcard.2007.07.029.
Singh P, Singh M, Gaur S, Kaur T (xuño de 2007). "The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype". Diabetes & Vascular Disease Research 4 (2): 124–29. PMID 17654446. doi:10.3132/dvdr.2007.030.
Qamar A, Khetarpal SA, Khera AV, Qasim A, Rader DJ, Reilly MP (2015). "Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics". Arteriosclerosis, Thrombosis, and Vascular Biology 35 (8): 1880–1888. PMC 4556282. PMID 26069232. doi:10.1161/ATVBAHA.115.305415.
Sacks FM, Zheng C, Cohn JS (2011). "Complexities of plasma apolipoprotein C-III metabolism". Journal of Lipid Research 52 (6): 1067–1070. PMC 3090227. PMID 21421846. doi:10.1194/jlr.E015701.
Kypreos KE (2008). "ABCA1 Promotes the de Novo Biogenesis of Apolipoprotein CIII-Containing HDL Particles in Vivo and Modulates the Severity of Apolipoprotein CIII-Induced Hypertriglyceridemia". Biochemistry 47 (39): 10491–10502. PMID 18767813. doi:10.1021/bi801249c.

nih.gov

ncbi.nlm.nih.gov

Khetarpal SA, Zeng X, Millar JS, Vitali C, Somasundara AVH, Zanoni P, Landro JA, Barucci N, Zavadoski WJ, Sun Z, de Haard H, Toth IV, Peloso GM, Natarajan P, Cuchel M, Lund-Katz S, Phillips MC, Tall AR, Kathiresan S, DaSilva-Jardine P, Yates NA, Rader D (2017). "A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels". Nature Medicine 23 (9): 1086–1094. PMC 5669375. PMID 28825717. doi:10.1038/nm.4390.
Vaith P, Assmann G, Uhlenbruck G (xuño de 1978). "Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins". Biochimica et Biophysica Acta (BBA) - General Subjects 541 (2): 234–40. PMID 208636. doi:10.1016/0304-4165(78)90396-3.
Nicolardi S, van der Burgt YE, Dragan I, Hensbergen PJ, Deelder AM (maio de 2013). "Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera". Journal of Proteome Research 12 (5): 2260–68. PMID 23527852. doi:10.1021/pr400136p.
Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM (febreiro de 2010). "Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins". Arteriosclerosis, Thrombosis, and Vascular Biology 30 (2): 239–45. PMC 2818784. PMID 19910636. doi:10.1161/ATVBAHA.109.197830.
Sundaram M, Zhong S, Bou Khalil M, Links PH, Zhao Y, Iqbal J, Hussain MM, Parks RJ, Wang Y, Yao Z (xaneiro de 2010). "Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions". Journal of Lipid Research 51 (1): 150–161. PMC 2789775. PMID 19622837. doi:10.1194/M900346-JLR200.
Sundaram M, Zhong S, Bou Khalil M, Zhou H, Jiang ZG, Zhao Y, Iqbal J, Hussain MM, Figeys D, Wang Y, Yao Z (xuño de 2010). "Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia". Journal of Lipid Research 51 (6): 1524–1534. PMC 3035516. PMID 20097930. doi:10.1194/jlr.M005108.
Qin W, Sundaram M, Wang Y, Zhou H, Zhong S, Chang CC, Manhas S, Yao EF, Parks RJ, McFie PJ, Stone SJ, Jiang ZG, Wang C, Figeys D, Jia W, Yao Z (agosto de 2011). "Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen". The Journal of Biological Chemistry 286 (31): 27769–27780. PMC 3149367. PMID 21676879. doi:10.1074/jbc.M110.203679.
Singh P, Singh M, Kaur TP, Grewal SS (novembro de 2008). "A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease". International Journal of Cardiology 130 (3): e93–5. PMID 17825930. doi:10.1016/j.ijcard.2007.07.029.
Singh P, Singh M, Gaur S, Kaur T (xuño de 2007). "The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype". Diabetes & Vascular Disease Research 4 (2): 124–29. PMID 17654446. doi:10.3132/dvdr.2007.030.
Qamar A, Khetarpal SA, Khera AV, Qasim A, Rader DJ, Reilly MP (2015). "Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics". Arteriosclerosis, Thrombosis, and Vascular Biology 35 (8): 1880–1888. PMC 4556282. PMID 26069232. doi:10.1161/ATVBAHA.115.305415.
Sacks FM, Zheng C, Cohn JS (2011). "Complexities of plasma apolipoprotein C-III metabolism". Journal of Lipid Research 52 (6): 1067–1070. PMC 3090227. PMID 21421846. doi:10.1194/jlr.E015701.
Kypreos KE (2008). "ABCA1 Promotes the de Novo Biogenesis of Apolipoprotein CIII-Containing HDL Particles in Vivo and Modulates the Severity of Apolipoprotein CIII-Induced Hypertriglyceridemia". Biochemistry 47 (39): 10491–10502. PMID 18767813. doi:10.1021/bi801249c.